Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
NCT 04262466 Brief Summary Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell…
Read more arrow_forwardNCT 04262466 Brief Summary Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell…
Read more arrow_forwardACTRN 12621001537842 Brief Summary This trial aims to determine whether NOX66 (idronoxil)…
Read more arrow_forwardNCT 05544552 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12623001216606 Brief Summary The purpose of the study is to investigate…
Read more arrow_forwardNCT 05267626 Brief Summary This is a first in human, open-label, multi-center…
Read more arrow_forwardNCT 06819735 Brief Summary This is a phase 1/2, dose-escalation and cohort-expansion…
Read more arrow_forwardNCT 07156136 Brief Summary Phase 1 First-in-human study of the safety and…
Read more arrow_forward